When a routine blood test during chemotherapy shows a sudden, sharp rise in a tumor marker, the first fear for many patients is whether the drug has stopped working. That worry feels even heavier when only a few cycles of treatment have passed. Yet a single jump in one marker is rarely enough, on its own, to conclude that the cancer has become resistant.
It helps to understand what resistance (drug resistance) actually means. It describes a situation in which the chemotherapy drug being used can no longer hold back the growth of cancer cells well enough. Cancer cells may gradually develop ways to evade a drug, or some tumors respond poorly to a particular drug from the start. Importantly, this conclusion is reached by weighing several pieces of information together, not by one number.
Tumor markers are helpful reference signals that hint at what may be happening inside the body, but they are not an exact ruler for tumor size. Their levels can swing for many reasons: inflammation, infection, changes in bile flow, differences between laboratories, and even a temporary rise early in treatment as cancer cells break down. For this reason, doctors look at the trend across several measurements alongside symptoms, rather than a single absolute value.
This is where imaging tests such as CT (computed tomography) or MRI play a central role. Only by seeing whether a lesion has actually grown, or whether new lesions have appeared, can the team judge whether the treatment is still working. Doctors combine the imaging findings, the marker trend, and any change in symptoms to assess the response and, if needed, discuss the next step.
Waiting for results is frightening and the days can feel long. Rather than placing everything on one number, it can help to write down your questions in advance and calmly ask, at your appointment, what the change means and what the plan is going forward.
This article is intended as general medical information and does not replace diagnosis or treatment for an individual patient. Please discuss any test results and treatment decisions with your own medical team.